People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Biotechnology, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncocyte Corp | — | Biotechnology | Series B | $83.0M | $119.2M | 2020 |
| Smart Health Diagnostics Co | — | Biotechnology | Series B | $17.3M | $1.8M | 2023 |
| RPM-One, Inc. | — | Other Technology | Series A | $8.6M | $5.5M | 2024 |
| ImmunoPrecise Antibodies Ltd. | — | Pharmaceuticals | Seed | $2.5M | $9.3M | 2024 |
Mitch Levine at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mitch Levine on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Greg Smith | 1 | 17 |
| Alfred D Kingsley | 1 | 6 |
| Michael D West | 1 | 6 |
| Natasha Tsai | 1 | 6 |
| Matthew Nunez | 1 | 4 |
| Kristin Taylor | 1 | 4 |
| Andrew Arno | 1 | 3 |
| Robert W Peabody | 1 | 3 |
| Joseph Wagner | 1 | 3 |
| Robert Burke | 1 | 3 |
| Russell Skibsted | 1 | 2 |
| Jennifer Levin Carter | 1 | 2 |
| Yonghong Wu | 1 | 2 |
| James Liu | 1 | 2 |
| Chris Buyse | 1 | 2 |
| Andrew W. Arno | 1 | 2 |
| Louis Silverman | 1 | 2 |
| Douglas T. Ross | 1 | 2 |
| Thomas D'Orazio | 1 | 2 |
| Ronald A Andrews | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.